Recommendations for the Role of Extracorporeal Treatments in the Management of Acute Methanol Poisoning
Critical Care Medicine2014Vol. 43(2), pp. 461–472
Citations Over TimeTop 1% of 2014 papers
Darren M. Roberts, Chris Yates, Bruno Mégarbane, James F. Winchester, Robert MacLaren, Sophie Gosselin, Thomas D. Nolin, Valéry Lavergne, Robert S. Hoffman, Marc Ghannoum
Abstract
Extracorporeal treatment has a valuable role in the treatment of patients with methanol poisoning. A range of clinical indications for extracorporeal treatment is provided and duration of therapy can be guided through the careful monitoring of biomarkers of exposure and toxicity. In the absence of severe poisoning, the decision to use extracorporeal treatment is determined by balancing the cost and complications of extracorporeal treatment to that of fomepizole or ethanol. Given regional differences in cost and availability of fomepizole and extracorporeal treatment, these decisions must be made at a local level.
Related Papers
- → Combined toxicity of methanol and formic acid: two cases of methanol poisoning(1998)21 cited
- → Combined toxicity of methanol and formic acid: two cases of methanol poisoning(1999)1 cited
- Susquehanna Chorale Spring Concert "Roots and Wings"(2017)
- → Genentech taps Affimed’s antibodies(2018)
- → Methanol(2014)